SEI Investments Portfolio holdings
AUM
$86.3B
This Quarter Return
+2.17%
1 Year Return
+22.26%
3 Year Return
+83.74%
5 Year Return
+138.48%
10 Year Return
+342.87%
AUM
$77.9B
AUM Growth
+$77.9B
(+1.1%)
Cap. Flow
+$3.81B
Cap. Flow
% of AUM
4.89%
Top 10 Holdings %
Top 10 Hldgs %
18.36%
Holding
2,835
New
160
Increased
1,235
Reduced
1,146
Closed
114
Top Buys
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
$797M |
| 2 |
Schwab US Large-Cap Value ETF
SCHV
|
$698M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
$529M |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
$205M |
| 5 |
Schwab U.S Small- Cap ETF
SCHA
|
$166M |
Top Sells
| 1 |
Intuit
INTU
|
$133M |
| 2 |
Advanced Micro Devices
AMD
|
$94.2M |
| 3 |
Mercado Libre
MELI
|
$92.8M |
| 4 |
Qiagen
QGEN
|
$74.2M |
| 5 |
Broadcom
AVGO
|
$72.1M |
Sector Composition
| 1 | Technology | 22% |
| 2 | Financials | 10.31% |
| 3 | Consumer Discretionary | 8.91% |
| 4 | Industrials | 8.64% |
| 5 | Healthcare | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
C4 Therapeutics
CCCC
$179M
| $44.6K | ﹤0.01% |
+12,399
| New | +$44.6K |
|
2602
Erasca
ERAS
$454M
| $41.9K | ﹤0.01% |
16,682
| – | – |
|
2603
Wheels Up
UP
$1.69B
| $41.8K | ﹤0.01% |
25,317
| – | – |
|
2604
Orchestra BioMed
OBIO
$148M
| $41.2K | ﹤0.01% |
10,290
| – | – |
|
2605
Larimar Therapeutics
LRMR
$318M
| $40.9K | ﹤0.01% |
10,573
| – | – |
|
2606
Hyliion Holdings
HYLN
$282M
| $40.5K | ﹤0.01% |
15,517
| – | – |
|
2607
Beyond Meat
BYND
$182M
| $40.3K | ﹤0.01% |
10,722
| – | – |
|
2608
B2Gold
BTG
$5.65B
| $39.7K | ﹤0.01% |
16,290
-11,717
| -42% | -$28.6K |
|
|
EU
2609
enCore Energy
EU
$445M
| $39.5K | ﹤0.01% |
11,570
| – | – |
|
2610
Hertz
HTZ
$1.75B
| $38.2K | ﹤0.01% |
10,443
-44
| -0.4% | -$161 |
|
2611
3D Systems Corporation
DDD
$280M
| $37.8K | ﹤0.01% |
11,525
| – | – |
|
2612
Energy Vault
NRGV
$340M
| $37.8K | ﹤0.01% |
16,564
| – | – |
|
2613
Acumen Pharmaceuticals
ABOS
$82.4M
| $37.5K | ﹤0.01% |
21,782
| – | – |
|
2614
Nordic American Tanker
NAT
$659M
| $36.5K | ﹤0.01% |
14,588
-78,205
| -84% | -$195K |
|
2615
Lyell Immunopharma
LYEL
$219M
| $35.8K | ﹤0.01% |
55,900
| – | – |
|
2616
Cerus
CERS
$243M
| $34.1K | ﹤0.01% |
22,140
| – | – |
|
|
SLRN
2617
DELISTED
ACELYRIN
SLRN
| $33.9K | ﹤0.01% |
10,782
| – | – |
|
2618
Microvision
MVIS
$343M
| $33.3K | ﹤0.01% |
25,404
| – | – |
|
2619
GoPro
GPRO
$236M
| $33.3K | ﹤0.01% |
30,527
-34
| -0.1% | -$37 |
|
2620
Werewolf Therapeutics
HOWL
$59.4M
| $31.6K | ﹤0.01% |
21,322
| – | – |
|
2621
Innoviz Technologies
INVZ
$315M
| $31.5K | ﹤0.01% |
18,740
-4,521
| -19% | -$7.6K |
|
|
QD
2622
Qudian
QD
$769M
| $30.3K | ﹤0.01% |
+10,731
| New | +$30.3K |
|
2623
GrafTech
EAF
$248M
| $30.2K | ﹤0.01% |
17,472
| – | – |
|
2624
ThredUp
TDUP
$1.3B
| $30.1K | ﹤0.01% |
21,636
| – | – |
|
2625
Sana Biotechnology
SANA
$721M
| $28.8K | ﹤0.01% |
17,668
| – | – |
|